VR Adviser as of Dec. 31, 2024
Portfolio Holdings for VR Adviser
VR Adviser holds 37 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 26.4 | $385M | 8.5M | 45.30 | |
| Ocular Therapeutix (OCUL) | 7.5 | $109M | 13M | 8.54 | |
| Enliven Therapeutics (ELVN) | 6.2 | $91M | 4.0M | 22.50 | |
| Praxis Precision Medicines I Com New (PRAX) | 5.2 | $76M | 990k | 76.96 | |
| Miragen Therapeutics (VRDN) | 5.1 | $74M | 3.9M | 19.17 | |
| Oruka Therapeutics (ORKA) | 4.4 | $64M | 3.3M | 19.39 | |
| Spyre Therapeutics Com New (SYRE) | 4.3 | $63M | 2.7M | 23.28 | |
| Pharvaris N V (PHVS) | 4.2 | $62M | 3.2M | 19.17 | |
| Kalvista Pharmaceuticals (KALV) | 3.6 | $53M | 6.2M | 8.47 | |
| Dyne Therapeutics (DYN) | 3.5 | $51M | 2.2M | 23.56 | |
| Cogent Biosciences (COGT) | 3.0 | $44M | 5.7M | 7.80 | |
| Erasca (ERAS) | 2.8 | $41M | 16M | 2.51 | |
| Dianthus Therapeutics (DNTH) | 2.6 | $38M | 1.7M | 21.80 | |
| Upstream Bio (UPB) | 2.6 | $38M | 2.3M | 16.44 | |
| Oric Pharmaceuticals (ORIC) | 2.4 | $36M | 4.4M | 8.07 | |
| Engene Holdings (ENGN) | 2.3 | $34M | 5.0M | 6.65 | |
| Merus N V (MRUS) | 1.7 | $25M | 592k | 42.05 | |
| Astria Therapeutics (ATXS) | 1.5 | $22M | 2.5M | 8.94 | |
| Cidara Therapeutics Com New (CDTX) | 1.4 | $21M | 766k | 26.88 | |
| Cullinan Oncology (CGEM) | 1.2 | $17M | 1.4M | 12.18 | |
| 4d Molecular Therapeutics In (FDMT) | 1.1 | $16M | 3.0M | 5.57 | |
| Artiva Biotherapeutics (ARTV) | 1.1 | $16M | 1.6M | 10.08 | |
| Mersana Therapeutics | 1.0 | $15M | 10M | 1.43 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.7 | $9.9M | 1.3M | 7.32 | |
| Aquestive Therapeutics (AQST) | 0.6 | $9.4M | 2.6M | 3.56 | |
| Applied Therapeutics (APLT) | 0.6 | $8.6M | 10M | 0.86 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.5 | $7.6M | 750k | 10.18 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $6.0M | 1.1M | 5.54 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.4 | $5.6M | 3.2M | 1.73 | |
| Trevi Therapeutics (TRVI) | 0.4 | $5.2M | 1.3M | 4.12 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.3 | $5.1M | 2.0M | 2.50 | |
| Century Therapeutics (IPSC) | 0.3 | $4.0M | 4.0M | 1.01 | |
| Casi Pharmaceuticals Ord Shs (CASI) | 0.2 | $2.8M | 987k | 2.83 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $2.2M | 1.6M | 1.43 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $1.3M | 208k | 6.19 | |
| Glycomimetics | 0.1 | $747k | 3.0M | 0.25 | |
| Instil Bio Com New (TIL) | 0.0 | $633k | 33k | 19.09 |
